BrainScope, a Bethesda, Maryland firm that’s been working with the U.S. Department of Defense to develop technology for assessing traumatic brain injuries (TBI), just won FDA clearance for its latest device, the Ahead 300. This the first of the company’s products that will actually be distributed commercially and it’s touted as their most advanced version.
It can provide a rapid electroencephalographic (EEG) assessment of a person who suffered a head injury, utilizing disposable electrodes and a connected smartphone to process the information. It relies on the firm’s proprietary algorithms and machine learning to spot certain patterns and correlations within the recorded brainwaves.
Following the test it produces a report that highlights important aspects that are of note. These can then be used to help pin down a diagnosis.
Link: BrainScope homepage…